Stocks360

Phreesia, Inc. (PHR)

Stock analysis · NYSE · Healthcare · Medical - Healthcare Information Services

Share: Facebook X WhatsApp SMS
$12.53

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$777.75M
PE (TTM)
72.76
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.84
Day Range
$12.20 – $12.55
52-wk Range
$7.77 – $23.78
Avg Volume
N/A
Volume
612.60K

Phreesia, Inc. (PHR) is a publicly traded company in the Healthcare sector. Latest price: $12.53. Market cap $777.75M. Trailing PE 72.76. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $22.66 2026-10-29 · $12.53 (-44.70%)

Earnings

Most Recent
Sep 2, 2026
EPS $0.03 vs est. $0.09
Missed by $0.06
Next Earnings
Dec 14, 2026
EPS estimate $0.13

Proprietary Signals

Signal snapshot temporarily unavailable.

About Phreesia, Inc.

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via s…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)72.76×
P/S (TTM)1.53×
P/B2.09×
P/FCF (TTM)10.03×
EV / EBITDA13.77×
EV / Sales1.52×
Earnings Yield1.35%
Free Cash Flow Yield9.97%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$772.75M
Revenue (TTM)$507.79M
Net Income (TTM)$10.48M
Free Cash Flow (TTM)$121.04M
Net Debt-$5.00M
Working Capital$109.67M
Gross Margin63.55%
Operating Margin3.19%
Net Margin2.06%
Return on Equity3.01%
Return on Invested Capital3.18%

Peers

Recent News

Related

Browse more tickers: sitemap